Home - Aragen Bioscience

GET IN TOUCH

Aragen Bioscience partners with biotechnology companies worldwide to advance biologics from discovery to development and manufacturing. Our integrated scientific capabilities and US–India operating model support the efficient progression of innovative therapies across the development lifecycle.

Biologics

Comprehensive biologics solutions for cell line development, bioproduction, process development and analytics.

Know More

Preclinical Efficacy Testing

Preclinical testing in multiple therapeutics, with well-established protocols.

Know More

CLD
Platforms

Royalty-free CHO-GS and CHO-DG 44

AMBR® 250

To streamline upstream process development

2.5
KL

GMP manufacturing capacity

15,000
sq ft.

Vivarium and laboratory facility

2000+
Studies

Preclinical efficacy studies

Who We Serve

Aragen Bioscience strongly supports innovation and partnership, catering to a diverse array of industries with dedication and expertise.

Biotech

Aragen Bioscience empowers biotechnology companies to explore new frontiers in research and development. Our expertise spans a multitude of areas, including recombinant protein production, cell line development, antibody engineering, and bioanalytical services.

Know more

Biosimilars

Aragen Bioscience works with several biosimilars companies and has performed successful clone development for leading biosimilars. As an expert in this space, Aragen Bioscience will provide the right platform and guidance to ensure quality and biosimilarity so that there are no surprises.

Know more

Animal Health

Aragen Bioscience is committed to partnering our technology with leading companies improving animal health for companion and farm animals.

Know more

Government and Academic Research Organizations

In close collaboration with academic and research institutions, Aragen Bioscience transforms scientific investigations into potential therapies. Our services extend from the inception of novel ideas to the realization of IND filings.

Know more

What do our clients say

"You have given us fantastic data! The top clone looks great by titer and quality. I think we have a pretty great clone to move forward with."

Animal Health Company

"The assay is performing well (great job setting it up, team Aragen!). The methods your team employed have helped us with background issues that we had previously with this assay. The sensitivity from standard curve is very good and it will help with future studies."

Biotech Company

"Aragen is our trusted partner in bringing innovative therapeutics to treat cancer patients."

Clinical Stage Biotech Company

"Working with Aragen was a fantastic experience! I am genuinely excited to continue our discussions about future collaborations."

Diagnostic Company

"We appreciate all the work done by Aragen which has allowed us to push projects and therapeutics development forward."

Immuno Oncology Company

"I greatly appreciate the effort and hard work put in by Aragen which allowed the successful expression and purification of our lead molecule."

Immunotherapy Company

"Out of all the CROs that I reached out to, Aragen has been the fastest, most responsive, and thorough."

Diagnostic Company

"Your attention to detail is truly impressive."

Immunotherapy Company

“Aragen Biosciences is a versatile contract research lab that keeps expanding their services. Most recently, they have been a solid performer for my company’s animal studies…The Aragen team is very good at communicating and they consistently deliver quality results Thank you Aragen!”

Elisabeth Gardiner, PhD, Chief Scientific Officer, Meditope Biosciences, Inc

News VIEW ALL

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

Know more

Events VIEW ALL

IPF Summit

September 29 - October 01, 2026

Know more

Biologics

Preclinical Efficacy Testing

Search

Live Webinar - Accelerating FDA Fast-Track Monoclonal Antibodies through integrated strategy

Wednesday, August 05, 2025 | 11am EST

Speakers:

Indraneel Sanyal, Gokul Ram

Prithwish Dey, Abhishek Bhatt

Live Webinar - Accelerating FDA Fast-Track Monoclonal Antibodies through integrated strategy

Wednesday, August 05, 2025 | 11am EST

Speakers:

Indraneel Sanyal, Gokul Ram

Prithwish Dey, Abhishek Bhatt

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months

Biologics

Preclinical Efficacy Testing

CLD Platforms

AMBR® 250

2.5 KL

15,000 sq ft.

2000+ Studies

Who We Serve

Biotech

Biosimilars

Animal Health

Government and Academic Research Organizations

What do our clients say

"You have given us fantastic data! The top clone looks great by titer and quality. I think we have a pretty great clone to move forward with."

"The assay is performing well (great job setting it up, team Aragen!). The methods your team employed have helped us with background issues that we had previously with this assay. The sensitivity from standard curve is very good and it will help with future studies."

"Aragen is our trusted partner in bringing innovative therapeutics to treat cancer patients."

"Working with Aragen was a fantastic experience! I am genuinely excited to continue our discussions about future collaborations."

"We appreciate all the work done by Aragen which has allowed us to push projects and therapeutics development forward."

"I greatly appreciate the effort and hard work put in by Aragen which allowed the successful expression and purification of our lead molecule."

"Out of all the CROs that I reached out to, Aragen has been the fastest, most responsive, and thorough."

"Your attention to detail is truly impressive."

“Aragen Biosciences is a versatile contract research lab that keeps expanding their services. Most recently, they have been a solid performer for my company’s animal studies…The Aragen team is very good at communicating and they consistently deliver quality results Thank you Aragen!”

News VIEW ALL

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

Events VIEW ALL

IPF Summit

Learn more about our end-to-end capabilities

CLD
Platforms

2.5
KL

15,000
sq ft.

2000+
Studies

Learn more about our end-
to-end capabilities